NCT05341427 is a NA clinical trial of electromagnetic device in Burn Wound, sponsored by Cairo University.

Who is sponsoring NCT05341427?

NCT05341427 is sponsored by Cairo University.

What drugs are being tested in NCT05341427?

Interventions in NCT05341427: electromagnetic device.

What condition does NCT05341427 study?

NCT05341427 studies Burn Wound.

Is NCT05341427 still recruiting?

NCT05341427 is currently status unknown. Last updated 3 June 2022.

Last reviewed 2022-06-03 · How we verify

NCT05341427

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DEVELOPMENT OF A CLINICAL PREDICTION RULES TO IDENTIFY EFFICACY OF PULSED ELECTROMAGNETIC THERAPY ON BURN WOUND HEALING

Status unknown NA Last updated 3 June 2022

What this trial tests

NA trial testing electromagnetic device in Burn Wound in 60 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
15 June 2022

20 June 2022

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 January 2022
Primary completion	15 June 2022
Estimated completion	20 June 2022
Sites	1 location across Egypt

Drugs / interventions tested

electromagnetic device

Conditions studied

Burn Wound — all drugs for Burn Wound →

Sponsor

Cairo University

Who can join

Adults 20 to 50, any sex, with Burn Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate whether patients' age, total burned surface area, wound stage and wound depth determine wound healing response to pulsed electromagnetic therapy in burn patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Burn Wound

Currently open trials in the same condition.

NCT06807021 — Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients · Phase 2, PHASE3 · recruiting
NCT06913270 — Virtual Reality Adjunct for Procedural Pain and Anxiety Management in Burn Wound Care · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05341427 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 3 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05341427.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing